Trade Cassava Sciences Inc - SAVA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.12 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.24 |
| Open | 2.19 |
| 1-Year Change | -92.18% |
| Day's Range | 2.19 - 2.35 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 20, 2024 | 2.30 | 0.12 | 5.50% | 2.18 | 2.35 | 2.18 |
| Dec 19, 2024 | 2.24 | -0.08 | -3.45% | 2.32 | 2.40 | 2.22 |
| Dec 18, 2024 | 2.36 | -0.12 | -4.84% | 2.48 | 2.57 | 2.33 |
| Dec 17, 2024 | 2.50 | -0.07 | -2.72% | 2.57 | 2.63 | 2.49 |
| Dec 16, 2024 | 2.60 | -0.08 | -2.99% | 2.68 | 2.77 | 2.58 |
| Dec 13, 2024 | 2.69 | 0.00 | 0.00% | 2.69 | 2.78 | 2.63 |
| Dec 12, 2024 | 2.73 | -0.05 | -1.80% | 2.78 | 2.79 | 2.65 |
| Dec 11, 2024 | 2.79 | 0.00 | 0.00% | 2.79 | 2.82 | 2.70 |
| Dec 10, 2024 | 2.84 | -0.02 | -0.70% | 2.86 | 2.97 | 2.78 |
| Dec 9, 2024 | 2.88 | -0.22 | -7.10% | 3.10 | 3.15 | 2.87 |
| Dec 6, 2024 | 3.15 | 0.20 | 6.78% | 2.95 | 3.21 | 2.94 |
| Dec 5, 2024 | 2.98 | 0.11 | 3.83% | 2.87 | 3.14 | 2.71 |
| Dec 4, 2024 | 2.86 | -0.37 | -11.46% | 3.23 | 3.30 | 2.84 |
| Dec 3, 2024 | 3.28 | -0.04 | -1.20% | 3.32 | 3.48 | 3.18 |
| Dec 2, 2024 | 3.39 | -0.23 | -6.35% | 3.62 | 3.67 | 3.34 |
| Nov 29, 2024 | 3.76 | -0.13 | -3.34% | 3.89 | 3.93 | 3.71 |
| Nov 27, 2024 | 3.86 | 0.32 | 9.04% | 3.54 | 4.07 | 3.54 |
| Nov 26, 2024 | 3.76 | -0.44 | -10.48% | 4.20 | 4.20 | 3.59 |
| Nov 25, 2024 | 4.23 | 0.10 | 2.42% | 4.13 | 4.78 | 3.75 |
| Nov 22, 2024 | 26.43 | -4.08 | -13.37% | 30.51 | 31.10 | 25.95 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Cassava Sciences Inc. Company profile
Cassava Science Inc is a clinical-stage biopharmaceutical company that specialises in detecting and treating Alzheimer’s disease, an incurable progressive neurologic disorder, which is . The company is listed on the Nasdaq under the ticker SAVA.
According to Cassava, over five million people in the US have Alzheimer’s. The company focuses on research and development to find new approaches for its treatment and diagnosis.
Cassava is developing Simufilam for the proposed treatment of Alzheimer's. According to the company, Simufilam is a proprietary oral drug candidate, developed in-house with academic collaborators. Simufilam, or PTI-125, is the company’s lead therapeutic product candidate. It’s currently (17 March) undergoing Phase 3 clinical studies.
SavaDx is the company’s investigational diagnostic for Alzheimer’s. According to the company, SavaDx is being developed to detect the disease with a simple blood test. However, SavaDx is still an early-stage product candidate and a lower priority than Simufilam, Cassava said.
Cassava was incorporated in 1998. It’s based in Austin, Texas, US. Remi Barbier has served as president, CEO and chairman of the board of directors since the company’s inception. Nadav Friedmann is the company’s chief medical officer. James Kupiec is the chief clinical development officer.
| Industry: | Bio Therapeutic Drugs |
6801 N Capital Of Texas Highway
Building 1; Suite 300
AUSTIN
TEXAS 78731
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com